The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.49
Bid: 6.02
Ask: 6.98
Change: 0.00 (0.00%)
Spread: 0.96 (15.947%)
Open: 6.49
High: 0.00
Low: 0.00
Prev. Close: 6.49
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Nov 2021 14:26

RNS Number : 0144T
Synairgen plc
19 November 2021
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Synairgen PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Polygon Global Partners LLP

Reade Eugene Griffith

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.) v

Name

Aurora Nominee Ltd

City and country of registered office (if applicable)

London, United Kingdom

5. Date on which the threshold was crossed or reached vi:

17/11/2021

6. Date on which issuer notified (DD/MM/YYYY):

19/11/2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

15.571

0

15.571

31,350,000

Position of previous notification (if

applicable)

12.913

2.427

15.341

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00B0381Z20

0

31,350,000

0

15.571

SUBTOTAL 8. A

31,350,000

15.571%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Reade Eugene Griffith

15.571

0

15.571

Polygon Global Partners LLP

15.571

0

15.571

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

Reade Eugene Griffith is the ultimate controlling natural person of Polygon Global Partners LLP, an investment manager which has investment discretion over certain funds and managed accounts.

 

Place of completion

London, United Kingdom

Date of completion

19 November 2021

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFFSLSLALIL
Date   Source Headline
22nd Apr 20155:03 pmRNSPosting of Annual Report and Accounts
5th Mar 201512:55 pmRNSRichard Griffiths increases stake to 6.1 percent
3rd Mar 20157:00 amRNSPreliminary Results
12th Feb 201512:44 pmRNSHolding(s) in Company
11th Nov 20142:34 pmRNSExercise of options
4th Nov 20147:00 amRNSGrant of Options
8th Oct 20147:00 amRNSExercise of options
25th Sep 20147:00 amRNSInterim results for the six months ended 30 June
17th Sep 20147:00 amRNSNotice of Interim Results
22nd Jul 20145:23 pmRNSHolding(s) in Company
22nd Jul 201411:11 amRNSHolding(s) in Company
22nd Jul 201411:08 amRNSHolding(s) in Company
21st Jul 20143:53 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSHolding(s) in Company
15th Jul 20143:13 pmRNSHolding(s) in Company
4th Jul 20142:44 pmRNSHolding(s) in Company
4th Jul 20147:00 amRNSPlacing
25th Jun 20147:00 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSLicence deal with AstraZeneca
9th Jun 20141:00 pmRNSResult of AGM
16th May 20147:00 amRNSNotice of AGM
9th May 20142:57 pmRNSNotice of Report and Accounts
20th Mar 20147:00 amRNSPreliminary Results
11th Mar 20145:05 pmRNSHolding(s) in Company
6th Mar 201412:58 pmRNSHolding(s) in Company
5th Mar 20147:00 amRNSLicensing Update, Placing & Notice of results
14th Oct 20139:05 amRNSExercise of Options
12th Aug 20137:00 amRNSHalf Yearly Report
18th Jul 20137:00 amRNSPositive anti-inflammatory and anti-viral data
3rd Jul 20133:05 pmRNSHolding(s) in Company
10th Jun 20131:45 pmRNSResult of AGM
21st May 201311:10 amRNSHolding(s) in Company
9th May 201312:45 pmRNSNotice of AGM
9th Apr 20134:26 pmRNSPosting of Annual Report
12th Mar 20137:00 amRNSGrant of Options
13th Feb 20137:00 amRNSPreliminary Results
5th Dec 20127:00 amRNSTrading Update
30th Oct 20121:44 pmRNSDirector/PDMR Shareholding
25th Sep 20127:00 amRNSExercise of Options
31st Aug 20127:00 amRNSSynairgen presents proof of concept study
10th Aug 20127:00 amRNSHalf Yearly Report
18th Jul 20127:00 amRNSPlacing
25th Jun 20121:30 pmRNSResult of AGM
22nd May 20127:30 amRNSProfessor Stephen Holgate given prestigious Award
1st May 201212:55 pmRNSHolding(s) in Company
19th Apr 20127:00 amRNSPositive Phase II asthma data
2nd Mar 20127:00 amRNSNotice of Report and Accounts
1st Feb 20127:00 amRNSPreliminary results
30th Jan 20127:00 amRNSNotice of Results
12th Dec 20117:00 amRNSDirector's dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.